|Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases|
AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ...
British journal of pharmacology 174 (11), 1325-1348, 2017
|ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment|
A Devi Khwairakpam, M Singh Shyamananda, B Lalduhsaki Sailo, ...
Current drug targets 16 (2), 156-163, 2015
|An update on pharmacological potential of boswellic acids against chronic diseases|
NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ...
International journal of molecular sciences 20 (17), 4101, 2019
|Tocotrienols: The promising analogues of vitamin E for cancer therapeutics|
BL Sailo, K Banik, G Padmavathi, M Javadi, D Bordoloi, ...
Pharmacological research 130, 259-272, 2018
|Magnolol: a neolignan from the magnolia family for the prevention and treatment of cancer|
AM Ranaware, K Banik, V Deshpande, G Padmavathi, NK Roy, G Sethi, ...
International journal of molecular sciences 19 (8), 2362, 2018
|Butein in health and disease: A comprehensive review|
G Padmavathi, NK Roy, D Bordoloi, F Arfuso, S Mishra, G Sethi, ...
Phytomedicine 25, 118-127, 2017
|Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far|
D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara
Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016
|Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets|
K Banik, AM Ranaware, V Deshpande, SP Nalawade, G Padmavathi, ...
Pharmacological research 144, 192-209, 2019
|Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression|
G Padmavathi, K Banik, J Monisha, D Bordoloi, B Shabnam, F Arfuso, ...
Cancer letters 432, 260-271, 2018
|Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases|
AB Kunnumakkara, K Banik, D Bordoloi, C Harsha, BL Sailo, ...
Frontiers in pharmacology 9, 686, 2018
|Potential of butein, a tetrahydroxychalcone to obliterate cancer|
G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ...
Phytomedicine 22 (13), 1163-1171, 2015
|NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance|
J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ...
Cancers 10 (7), 228, 2018
|Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress|
D Thomas, S Govindhan, EC Baiju, G Padmavathi, AB Kunnumakkara, ...
Journal of basic and clinical physiology and pharmacology 26 (5), 485-490, 2015
|Specific targeting of Akt kinase isoforms: Taking the precise path for prevention and treatment of cancer|
N Kishor Roy, D Bordoloi, J Monisha, G Padmavathi, J Kotoky, R Golla, ...
Current drug targets 18 (4), 421-435, 2017
|TIPE family of proteins and its implications in different chronic diseases|
D Bordoloi, K Banik, B Shabnam, G Padmavathi, J Monisha, F Arfuso, ...
International journal of molecular sciences 19 (10), 2974, 2018
|NF-κB blockers gifted by mother nature: Prospectives in cancer cell chemosensitization|
J Monisha, G Padmavathi, NK Roy, A Deka, D Bordoloi, A Anip, ...
Current pharmaceutical design 22 (27), 4173-4200, 2016
|Nuclear factor kappa B: a potential target to persecute head and neck cancer|
J Monisha, N Kishor Roy, D Bordoloi, A Kumar, R Golla, J Kotoky, ...
Current drug targets 18 (2), 232-253, 2017
|Sorcin a potential molecular target for cancer therapy|
B Shabnam, G Padmavathi, K Banik, S Girisa, J Monisha, G Sethi, L Fan, ...
Translational oncology 11 (6), 1379-1389, 2018
|Potential application of zerumbone in the prevention and therapy of chronic human diseases|
YP Singh, S Girisa, K Banik, S Ghosh, P Swathi, M Deka, G Padmavathi, ...
Journal of Functional Foods 53, 248-258, 2019
|Acorus calamus: a bio-reserve of medicinal values|
AD Khwairakpam, YD Damayenti, A Deka, J Monisha, NK Roy, ...
Journal of basic and clinical physiology and pharmacology 29 (2), 107-122, 2018